Related Subjects:
|Ferritin
|CEA
|ESR
|CRP
|ALP
|LDH
|HbA1c
|Alpha Fetoprotein
|Anti-Hu ab
|Biochemical Lab values
|Adrenal Physiology
|Primary hyperaldosteronism (Conn's syndrome)
🧪 Aldosterone–Renin Ratio (ARR) is the key screening test for primary hyperaldosteronism (Conn’s syndrome), a potentially curable cause of hypertension.
💡 Excess aldosterone → sodium and water retention → hypertension, while renin is suppressed due to negative feedback.
📖 About
- ARR is a screening test in hypertensive patients at risk of primary hyperaldosteronism.
- Interpreted in context of renin and aldosterone levels.
- Renin–aldosterone axis is regulated by renal perfusion, sodium intake, and potassium balance.
- Patients should be euvolaemic, on a normal diet with adequate sodium intake, and have corrected potassium before testing.
- Routine clotting/platelet checks are not required before testing.
🎯 Indications
- Hypertension with unexplained or refractory hypokalaemia.
- Resistant hypertension (≥3 antihypertensives ineffective).
- Severe hypertension (SBP >160 or DBP >100 mmHg).
- Hypertension with adrenal incidentaloma.
- Young age of onset hypertension or family history of early stroke/Conn’s.
🧪 Plasma Renin Activity (PRA)
- Sometimes measured alone (e.g. Addison’s disease, CAH) to monitor adequacy of mineralocorticoid replacement.
- In Conn’s, renin is characteristically suppressed.
📊 Normal Values
- Aldosterone: ≤ 630 pmol/L (upright, adults).
- Renin (recumbent): 1.1–2.7 pmol/mL/h.
- Renin (upright): 2.8–4.5 pmol/mL/h.
- Random sample: 0.5–3.5 pmol/mL/h.
⚠️ Preparation
- Medications: Stop spironolactone, eplerenone, amiloride, and triamterene ≥6 weeks before test if safe.
Other antihypertensives (ACEi, ARBs, diuretics, beta-blockers, CCBs) may interfere and should ideally be stopped, but only if clinically safe. Substitute with doxazosin, verapamil, or hydralazine if BP control needed.
- Potassium: Correct hypokalaemia before test (low K⁺ suppresses aldosterone).
- Sodium intake: Normal diet, avoid restriction or excessive intake.
- Posture: Seated for 30 mins prior to venepuncture (standardisation reduces false results).
- Sample handling: Blood in EDTA tube, kept at room temp (do not chill, as renin cryoactivates). Send immediately to lab.
🧾 Sample Requirements
- Adults: 4 mL venous blood in EDTA tube.
- Notify lab in advance if ARR is being performed.
📈 Interpretation
- ARR >35 with aldosterone >300 pmol/L → highly suggestive of primary hyperaldosteronism (Conn’s syndrome).
Sensitivity ~100%, specificity ~90%.
- False negatives: ongoing ACEi/ARB/diuretics, low sodium intake, hypokalaemia.
- False positives: beta-blockers (suppress renin), poor posture control.
🔎 Next Steps if ARR Positive
- Confirm with suppression test (saline infusion test, oral sodium loading, fludrocortisone suppression test).
- Adrenal imaging (CT) to assess for adenoma vs hyperplasia.
- Adrenal vein sampling (gold standard) if surgical treatment considered.
💡 Clinical Pearl: ARR is a screening test only.
Always confirm with suppression testing before labelling as Conn’s syndrome. Early recognition is vital - surgical cure is possible in unilateral adenoma, while bilateral hyperplasia is treated medically with mineralocorticoid antagonists.